Abortion Drug Bill In Oklahoma Blocked By Judge

The Hope Center for Women is the first area abortion clinic to distribute the new Mifeprex pill that terminates a pregnancy, December 1. The pill commonly refered to as RU-486 was approved in September and can be taken by women up to the seventh week of pregnancy. The drug blocks the hormone that sustains the embryo and then unhooks it from the uterine wall.

A judge blocked an abortion law in Oklahoma Wednesday that would have limited the number of abortions performed in the state by regulating how doctors can prescribe abortion drugs.

"We're thrilled that women in Oklahoma will continue to be able to access medical care that accounts for scientific evidence, sound medical judgment and advancements in medicine," said Michelle Movahed, an attorney for the New York-based Center for Reproductive Rights, told The Associated Press. The organization challenged the law on behalf of Nova Health Systems, a provider in Tulsa, and the nonprofit group Oklahoma Coalition for Reproductive Justice.

The bill which would have gone into effect Nov. 1, prohibits doctors from prescribing off-label uses for drugs and requires them to adhere only to regulations by the U.S. Food and Drug Administration. Doctors must also examine women, document certain medical conditions and follow up with them in appointments.

Movahed told the AP that 21 percent of all drugs are prescribed for off-label use, and that studies have shown that using the abortion drug mifepristone with misoprostol, often used for treating ulcers, is safe and effective.

Oklahoma County District Judge Daniel Owens issued a temporary injunction against the measure, which the GOP-controlled legislature passed earlier this year before Gov. Mary Fallin signed it into law. Attorneys for the state argued that the drugs are dangerous and should be more tightly controlled.

Attorney General Scott Pruitt said that it "is unfortunate for the state and our public health, but it is not a surprise with new legislative provisions being tested."

Print Article